| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.953 | 0 | 0.962 | Sodium/glucose cotransporter inhibitor | 0.841 0 DBMET02141 0.962 0 DBMET02142 0.958 0 DBMET02143 | DBMET02142 | |
| 0.951 | 0.004 | 0.951 | Cyclophilin D inhibitor | 0.915 0.004 DBMET02141 0.943 0.004 DBMET02142 0.943 0.004 DBMET02143 | ||
| 0.946 | 0 | 0.96 | Sodium/glucose cotransporter 2 inhibitor | 0.822 0 DBMET02141 0.955 0 DBMET02142 0.96 0 DBMET02143 | DBMET02143 | |
| 0.811 | 0.004 | 0.837 | Hypoglycemic | 0.8 0.004 DBMET02141 0.837 0.004 DBMET02142 0.824 0.004 DBMET02143 | DBMET02142 | |
| 0.786 | 0.002 | 0.868 | AMP-activated protein kinase stimulant | 0.584 0.003 DBMET02141 0.868 0.001 DBMET02142 0.857 0.001 DBMET02143 | DBMET02142 | |
| 0.749 | 0.008 | 0.749 | Antiobesity | 0.378 0.075 DBMET02141 0.64 0.016 DBMET02142 0.67 0.013 DBMET02143 | ||
| 0.573 | 0.061 | 0.75 | Antiinflammatory | 0.649 0.041 DBMET02141 0.75 0.022 DBMET02142 0.726 0.026 DBMET02143 | DBMET02142 | |
| 0.51 | 0.043 | 0.771 | Transcription factor NF kappa B inhibitor | 0.413 0.061 DBMET02141 0.771 0.015 DBMET02142 0.719 0.018 DBMET02143 | DBMET02142 | |
| 0.462 | 0.026 | 0.604 | Apoptosis antagonist | 0.604 0.009 DBMET02141 0.563 0.013 DBMET02142 0.561 0.014 DBMET02143 | DBMET02141 | |
| 0.471 | 0.037 | 0.672 | Cholesterol antagonist | 0.49 0.034 DBMET02141 0.672 0.01 DBMET02142 0.462 0.039 DBMET02143 | DBMET02142 | |
| 0.406 | 0.034 | 0.573 | Antioxidant | 0.572 0.013 DBMET02141 0.573 0.013 DBMET02142 0.573 0.013 DBMET02143 | DBMET02143 | |
| 0.402 | 0.043 | 0.549 | Immunomodulator | 0.263 0.105 DBMET02141 0.536 0.018 DBMET02142 0.549 0.017 DBMET02143 | DBMET02143 | |
| 0.376 | 0.056 | 0.691 | Antithrombotic | 0.389 0.052 DBMET02141 0.691 0.009 DBMET02142 0.658 0.011 DBMET02143 | DBMET02142 | |
| 0.332 | 0.018 | 0.353 | Melanin inhibitor | 0.265 0.026 DBMET02141 0.353 0.016 DBMET02142 0.21 0.037 DBMET02143 | DBMET02142 | |
| 0.336 | 0.023 | 0.434 | Platelet adhesion inhibitor | 0.288 0.038 DBMET02141 0.434 0.009 DBMET02142 0.418 0.01 DBMET02143 | DBMET02142 | |
| 0.346 | 0.04 | 0.512 | Free radical scavenger | 0.407 0.028 DBMET02141 0.51 0.015 DBMET02142 0.512 0.015 DBMET02143 | DBMET02143 | |
| 0.34 | 0.038 | 0.379 | Hypolipemic | 0.203 0.092 DBMET02141 0.369 0.031 DBMET02142 0.379 0.029 DBMET02143 | DBMET02143 | |
| 0.339 | 0.041 | 0.512 | Tumour necrosis factor alpha release inhibitor | 0.454 0.019 DBMET02141 0.441 0.021 DBMET02142 0.512 0.013 DBMET02143 | DBMET02143 | |
| 0.318 | 0.025 | 0.455 | Hepatoprotectant | 0.339 0.021 DBMET02141 0.455 0.009 DBMET02142 0.445 0.01 DBMET02143 | DBMET02142 | |
| 0.328 | 0.039 | 0.592 | Angiogenesis stimulant | 0.592 0.007 DBMET02141 0.568 0.008 DBMET02142 0.568 0.008 DBMET02143 | DBMET02141 | |
| 0.338 | 0.051 | 0.446 | Interleukin 2 agonist | 0.372 0.037 DBMET02141 0.381 0.033 DBMET02142 0.446 0.016 DBMET02143 | DBMET02143 | |
| 0.398 | 0.115 | 0.561 | Apoptosis agonist | 0.486 0.079 DBMET02141 0.561 0.058 DBMET02142 0.519 0.069 DBMET02143 | DBMET02142 | |
| 0.342 | 0.059 | 0.392 | Vasodilator, coronary | 0.229 0.155 DBMET02141 0.392 0.038 DBMET02142 0.387 0.039 DBMET02143 | DBMET02142 | |
| 0.3 | 0.018 | 0.481 | Amylase inhibitor | 0.287 0.02 DBMET02141 0.481 0.006 DBMET02142 0.25 0.028 DBMET02143 | DBMET02142 | |
| 0.296 | 0.018 | 0.359 | NOS3 expression enhancer | 0.25 0.026 DBMET02141 0.301 0.018 DBMET02142 0.359 0.011 DBMET02143 | DBMET02143 | |
| 0.274 | 0.007 | 0.386 | Selectin antagonist | 0.329 0.004 DBMET02141 0.386 0.003 DBMET02142 0.356 0.004 DBMET02143 | DBMET02142 | |
| 0.361 | 0.096 | 0.639 | Antibacterial | 0.475 0.048 DBMET02141 0.639 0.014 DBMET02142 0.583 0.022 DBMET02143 | DBMET02142 | |
| 0.281 | 0.023 | 0.319 | Interferon gamma antagonist | 0.203 0.039 DBMET02141 0.319 0.017 DBMET02142 0.27 0.025 DBMET02143 | DBMET02142 | |
| 0.34 | 0.092 | 0.476 | Immunosuppressant | 0.34 0.092 DBMET02141 0.476 0.04 DBMET02142 0.463 0.043 DBMET02143 | DBMET02142 | |
| 0.259 | 0.013 | 0.265 | UDP-glucose 4-epimerase inhibitor | 0.15 0.029 DBMET02141 0.265 0.012 DBMET02142 0.208 0.017 DBMET02143 | DBMET02142 | |
| 0.272 | 0.027 | 0.272 | Neurotrophic factor enhancer | 0.224 0.056 DBMET02141 0.221 0.058 DBMET02142 0.167 0.114 DBMET02143 | ||
| 0.366 | 0.133 | 0.366 | Caspase 9 stimulant | 0.275 0.222 DBMET02141 0.337 0.156 DBMET02142 0.332 0.161 DBMET02143 | ||
| 0.265 | 0.048 | 0.382 | Nitric oxide antagonist | 0.348 0.032 DBMET02141 0.382 0.028 DBMET02142 0.382 0.028 DBMET02143 | DBMET02143 | |
| 0.251 | 0.049 | 0.251 | RNA-directed DNA polymerase inhibitor | 0.168 0.157 DBMET02141 0.208 0.089 DBMET02142 | ||
| 0.224 | 0.034 | 0.251 | Protein kinase stimulant | 0.251 0.026 DBMET02141 0.231 0.032 DBMET02142 0.122 0.091 DBMET02143 | DBMET02141 | |
| 0.274 | 0.087 | 0.483 | Immunostimulant | 0.249 0.096 DBMET02141 0.483 0.031 DBMET02142 0.446 0.038 DBMET02143 | DBMET02142 | |
| 0.25 | 0.067 | 0.3 | DNA synthesis inhibitor | 0.202 0.121 DBMET02141 0.3 0.044 DBMET02142 0.236 0.077 DBMET02143 | DBMET02142 | |
| 0.201 | 0.035 | 0.221 | Hexokinase inhibitor | 0.18 0.049 DBMET02141 0.221 0.025 DBMET02142 0.148 0.081 DBMET02143 | DBMET02142 | |
| 0.188 | 0.029 | 0.188 | CF transmembrane conductance regulator agonist | 0.134 0.109 DBMET02143 | ||
| 0.15 | 0.007 | 0.15 | Phosphorylase inhibitor | 0.041 0.036 DBMET02141 0.126 0.009 DBMET02142 0.09 0.014 DBMET02143 | ||
| 0.189 | 0.048 | 0.215 | Interleukin 6 antagonist | 0.199 0.041 DBMET02141 0.215 0.033 DBMET02142 0.203 0.039 DBMET02143 | DBMET02142 | |
| 0.182 | 0.047 | 0.274 | Insulin secretagoues | 0.274 0.016 DBMET02141 0.26 0.018 DBMET02142 0.216 0.029 DBMET02143 | DBMET02141 | |
| 0.163 | 0.042 | 0.163 | DNA polymerase I inhibitor | 0.122 0.067 DBMET02141 0.139 0.056 DBMET02142 0.137 0.057 DBMET02143 | ||
| 0.158 | 0.044 | 0.272 | Monophenol monooxygenase inhibitor | 0.116 0.064 DBMET02141 0.272 0.021 DBMET02142 0.185 0.037 DBMET02143 | DBMET02142 | |
| 0.173 | 0.069 | 0.173 | Phospholipase C inhibitor | |||
| 0.17 | 0.068 | 0.275 | Thrombolytic | 0.222 0.042 DBMET02141 0.275 0.028 DBMET02142 0.252 0.033 DBMET02143 | DBMET02142 | |
| 0.248 | 0.15 | 0.248 | Toll-Like receptor agonist | 0.224 0.175 DBMET02143 | ||
| 0.124 | 0.026 | 0.124 | Phosphodiesterase 4D inhibitor | |||
| 0.168 | 0.073 | 0.215 | ATPase inhibitor | 0.169 0.072 DBMET02141 0.215 0.027 DBMET02142 0.158 0.088 DBMET02143 | DBMET02142 | |
| 0.241 | 0.156 | 0.241 | Toll-Like receptor 7 agonist | |||
| 0.136 | 0.055 | 0.278 | Cell adhesion inhibitor | 0.109 0.075 DBMET02141 0.278 0.012 DBMET02142 0.219 0.02 DBMET02143 | DBMET02142 | |
| 0.213 | 0.137 | 0.213 | Hypoxia-inducible factor 1 alpha inhibitor | 0.204 0.148 DBMET02142 | ||
| 0.11 | 0.035 | 0.16 | NADH dehydrogenase inhibitor | 0.087 0.062 DBMET02141 0.108 0.036 DBMET02142 0.16 0.015 DBMET02143 | DBMET02143 | |
| 0.189 | 0.114 | 0.338 | Peptidyltransferase inhibitor | 0.28 0.033 DBMET02141 0.338 0.014 DBMET02142 0.301 0.024 DBMET02143 | DBMET02142 | |
| 0.128 | 0.057 | 0.179 | DNA repair enzyme inhibitor | 0.111 0.094 DBMET02141 0.179 0.014 DBMET02142 0.142 0.039 DBMET02143 | DBMET02142 | |
| 0.116 | 0.048 | 0.172 | Toll-Like receptor 4 antagonist | 0.139 0.028 DBMET02141 0.142 0.026 DBMET02142 0.172 0.012 DBMET02143 | DBMET02143 | |
| 0.189 | 0.131 | 0.189 | 5 Hydroxytryptamine release stimulant | 0.177 0.144 DBMET02141 0.178 0.143 DBMET02142 | ||
| 0.118 | 0.063 | 0.145 | Microtubule formation inhibitor | 0.119 0.062 DBMET02142 0.145 0.04 DBMET02143 | DBMET02143 | |
| 0.228 | 0.173 | 0.228 | Calcium channel activator | |||
| 0.097 | 0.042 | 0.146 | Transcription factor NF kappa B stimulant | 0.125 0.023 DBMET02141 0.146 0.017 DBMET02142 0.11 0.031 DBMET02143 | DBMET02142 | |
| 0.178 | 0.124 | 0.268 | Vasodilator | 0.2 0.105 DBMET02141 0.243 0.073 DBMET02142 0.268 0.06 DBMET02143 | DBMET02143 | |
| 0.104 | 0.049 | 0.15 | Uric acid excretion stimulant | 0.144 0.025 DBMET02142 0.15 0.023 DBMET02143 | DBMET02143 | |
| 0.124 | 0.073 | 0.215 | Cyclooxygenase 3 inhibitor | 0.126 0.071 DBMET02141 0.215 0.014 DBMET02142 0.17 0.033 DBMET02143 | DBMET02142 | |
| 0.253 | 0.202 | 0.253 | Calcium channel L-type activator | |||
| 0.155 | 0.108 | 0.319 | Non-steroidal antiinflammatory agent | 0.319 0.024 DBMET02142 0.246 0.045 DBMET02143 | DBMET02142 | |
| 0.066 | 0.02 | 0.069 | Alpha-mannosidase inhibitor | 0.06 0.026 DBMET02141 0.069 0.018 DBMET02142 0.052 0.04 DBMET02143 | DBMET02142 | |
| 0.054 | 0.011 | 0.085 | Antibiotic Aminoglycoside-like | 0.081 0.004 DBMET02141 0.085 0.004 DBMET02142 0.064 0.007 DBMET02143 | DBMET02142 | |
| 0.07 | 0.031 | 0.075 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.075 0.027 DBMET02142 | DBMET02142 | |
| 0.089 | 0.051 | 0.186 | Antineoplastic antibiotic | 0.186 0.024 DBMET02141 0.18 0.025 DBMET02142 0.148 0.031 DBMET02143 | DBMET02141 | |
| 0.045 | 0.01 | 0.045 | Ceramide glucosyltransferase inhibitor | |||
| 0.157 | 0.124 | 0.157 | Insulin sensitizer | 0.145 0.141 DBMET02143 | ||
| 0.128 | 0.099 | 0.368 | Hemostatic | 0.365 0.01 DBMET02142 0.368 0.01 DBMET02143 | DBMET02143 | |
| 0.052 | 0.023 | 0.058 | Mannosidase inhibitor | 0.045 0.032 DBMET02141 0.058 0.018 DBMET02142 | DBMET02142 | |
| 0.194 | 0.165 | 0.194 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.089 | 0.062 | 0.09 | Triose-phosphate isomerase inhibitor | 0.09 0.06 DBMET02142 | DBMET02142 | |
| 0.035 | 0.008 | 0.035 | Adenosine kinase inhibitor | |||
| 0.088 | 0.062 | 0.088 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.119 | 0.095 | 0.216 | Lipid peroxidase inhibitor | 0.118 0.095 DBMET02141 0.209 0.038 DBMET02142 0.216 0.035 DBMET02143 | DBMET02143 | |
| 0.051 | 0.028 | 0.051 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.036 | 0.014 | 0.036 | Uridine phosphorylase inhibitor | |||
| 0.157 | 0.134 | 0.157 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.032 | 0.01 | 0.032 | Adenosine A1 receptor agonist | 0.022 0.019 DBMET02141 0.024 0.017 DBMET02142 | ||
| 0.196 | 0.175 | 0.279 | Caspase 3 stimulant | 0.215 0.148 DBMET02141 0.256 0.107 DBMET02142 0.279 0.09 DBMET02143 | DBMET02143 | |
| 0.078 | 0.058 | 0.078 | Phosphodiesterase 3A inhibitor | |||
| 0.108 | 0.09 | 0.108 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.094 | 0.076 | 0.195 | Expectorant | 0.195 0.021 DBMET02142 0.14 0.039 DBMET02143 | DBMET02142 | |
| 0.039 | 0.023 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.09 | 0.075 | 0.09 | Bronchodilator | |||
| 0.084 | 0.069 | 0.101 | ATPase (Vacuolar H+) inhibitor | 0.101 0.039 DBMET02141 0.1 0.039 DBMET02142 0.085 0.067 DBMET02143 | DBMET02141 | |
| 0.103 | 0.092 | 0.103 | Estrogen antagonist | |||
| 0.067 | 0.057 | 0.079 | Lipase inhibitor | 0.071 0.053 DBMET02141 0.075 0.049 DBMET02142 0.079 0.044 DBMET02143 | DBMET02143 | |
| 0.073 | 0.063 | 0.137 | Cell adhesion molecule inhibitor | 0.137 0.018 DBMET02142 0.135 0.019 DBMET02143 | DBMET02142 | |
| 0.089 | 0.08 | 0.155 | Topoisomerase I inhibitor | 0.091 0.078 DBMET02141 0.155 0.039 DBMET02142 0.123 0.054 DBMET02143 | DBMET02142 | |
| 0.021 | 0.013 | 0.022 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.022 0.012 DBMET02141 0.018 0.016 DBMET02143 | DBMET02141 | |
| 0.022 | 0.019 | 0.06 | Protein 30S ribosomal subunit inhibitor | 0.052 0.008 DBMET02141 0.06 0.006 DBMET02142 0.03 0.013 DBMET02143 | DBMET02142 | |
| 0.06 | 0.059 | 0.06 | Potassium channel large-conductance Ca-activated activator | |||
| 0.09 | 0.089 | 0.09 | Cystathionine beta-synthase inhibitor | |||
| 0.027 | 0.026 | 0.042 | Squalene synthetase inhibitor | 0.039 0.019 DBMET02142 0.042 0.017 DBMET02143 | DBMET02143 | |
| 0.064 | 0.066 | 0.078 | Na+ K+ transporting ATPase inhibitor | 0.078 0.052 DBMET02141 0.074 0.056 DBMET02142 0.074 0.057 DBMET02143 | DBMET02141 | |
| 0.044 | 0.048 | 0.093 | Protein 50S ribosomal subunit inhibitor | 0.087 0.017 DBMET02141 0.093 0.015 DBMET02142 0.082 0.019 DBMET02143 | DBMET02142 | |
| 0.164 | 0.17 | 0.171 | Nitric-oxide synthase stimulant | 0.171 0.15 DBMET02141 | DBMET02141 | |
| 0.025 | 0.033 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.022 DBMET02142 | DBMET02142 | |
| 0.038 | 0.047 | 0.046 | Microtubule stabilization | 0.042 0.039 DBMET02142 0.046 0.033 DBMET02143 | DBMET02143 | |
| 0.011 | 0.022 | 0.225 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.225 0.002 DBMET02141 | DBMET02141 | |
| 0.053 | 0.065 | 0.088 | Phosphofructokinase-1 inhibitor | 0.088 0.037 DBMET02142 | DBMET02142 | |
| 0.077 | 0.089 | 0.082 | Thioredoxin inhibitor | 0.082 0.078 DBMET02142 | DBMET02142 | |
| 0.081 | 0.102 | 0.13 | Protein-tyrosine phosphatase 1B inhibitor | 0.108 0.071 DBMET02142 0.13 0.056 DBMET02143 | DBMET02143 | |
| 0.076 | 0.105 | 0.127 | Xanthine oxidase inhibitor | 0.127 0.044 DBMET02142 0.123 0.046 DBMET02143 | DBMET02142 | |
| 0.172 | 0.205 | 0.285 | Angiogenesis inhibitor | 0.285 0.1 DBMET02142 0.284 0.101 DBMET02143 | DBMET02142 | |
| 0.045 | 0.081 | 0.062 | Nitric oxide donor | 0.058 0.053 DBMET02142 0.062 0.044 DBMET02143 | DBMET02143 | |
| 0.031 | 0.068 | 0.049 | Aldose reductase inhibitor | 0.045 0.044 DBMET02142 0.049 0.04 DBMET02143 | DBMET02143 | |
| 0.015 | 0.053 | 0.046 | Arginase inhibitor | 0.046 0.018 DBMET02142 | DBMET02142 | |
| 0.077 | 0.12 | 0.151 | Beta glucuronidase inhibitor | 0.122 0.044 DBMET02142 0.151 0.024 DBMET02143 | DBMET02143 | |
| 0.047 | 0.09 | 0.056 | Lipocortins synthesis agonist | 0.056 0.046 DBMET02142 0.054 0.053 DBMET02143 | DBMET02142 | |
| 0.03 | 0.074 | 0.097 | Neuraminidase (Influenza A) inhibitor | 0.097 0.004 DBMET02141 0.041 0.04 DBMET02142 0.045 0.031 DBMET02143 | DBMET02141 | |
| 0.049 | 0.094 | 0.07 | Histone deacetylase stimulant | 0.066 0.06 DBMET02141 0.07 0.055 DBMET02142 | DBMET02142 | |
| 0.049 | 0.094 | 0.07 | Histone deacetylase SIRT1 stimulant | 0.066 0.06 DBMET02141 0.07 0.055 DBMET02142 | DBMET02142 | |
| 0.072 | 0.119 | 0.12 | EphA2 antagonist | 0.12 0.054 DBMET02143 | DBMET02143 | |
| 0.098 | 0.147 | 0.133 | Protein-tyrosine phosphatase inhibitor | 0.12 0.113 DBMET02142 0.133 0.098 DBMET02143 | DBMET02143 | |
| 0.125 | 0.177 | 0.238 | Platelet antagonist | 0.222 0.086 DBMET02142 0.238 0.078 DBMET02143 | DBMET02143 | |
| 0.019 | 0.071 | 0.031 | Toll-Like receptor 4 agonist | 0.028 0.015 DBMET02142 0.031 0.01 DBMET02143 | DBMET02143 | |
| 0.055 | 0.114 | 0.077 | Glycine receptor antagonist | 0.077 0.062 DBMET02143 | DBMET02143 | |
| 0.087 | 0.147 | 0.121 | Interleukin 4 antagonist | 0.121 0.084 DBMET02143 | DBMET02143 | |
| 0.044 | 0.105 | 0.134 | Neuraminidase (influenza) inhibitor | 0.134 0.009 DBMET02141 0.061 0.051 DBMET02142 0.07 0.036 DBMET02143 | DBMET02141 | |
| 0.116 | 0.194 | 0.254 | Antiamyloidogenic | 0.163 0.13 DBMET02142 0.254 0.069 DBMET02143 | DBMET02143 | |
| 0.032 | 0.112 | 0.055 | Glucose-6-phosphate translocase inhibitor | 0.055 0.029 DBMET02142 0.05 0.039 DBMET02143 | DBMET02142 | |
| 0.033 | 0.116 | 0.079 | Heparanase inhibitor | 0.079 0.007 DBMET02142 0.065 0.016 DBMET02143 | DBMET02142 | |
| 0.066 | 0.153 | 0.105 | Alkylator | 0.105 0.083 DBMET02142 | DBMET02142 | |
| 0.038 | 0.141 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.032 DBMET02143 | DBMET02143 | |
| 0.149 | 0.264 | 0.327 | Alpha-glucosidase inhibitor | 0.301 0.159 DBMET02142 0.327 0.147 DBMET02143 | DBMET02143 | |
| 0.022 | 0.139 | 0.126 | Neuraminidase inhibitor | 0.126 0.009 DBMET02141 | DBMET02141 | |
| 0.079 | 0.2 | 0.206 | Cell wall synthesis inhibitor | 0.206 0.028 DBMET02142 0.179 0.04 DBMET02143 | DBMET02142 | |
| 0.075 | 0.199 | 0.204 | Anticoagulant | 0.204 0.051 DBMET02142 0.19 0.057 DBMET02143 | DBMET02142 | |
| 0.151 | 0.284 | 0.414 | Histamine release inhibitor | 0.414 0.068 DBMET02142 0.203 0.199 DBMET02143 | DBMET02142 | |
| 0.055 | 0.202 | 0.103 | Beta amyloid protein antagonist | 0.103 0.086 DBMET02143 | DBMET02143 | |
| 0.087 | 0.235 | 0.198 | Interleukin agonist | 0.163 0.155 DBMET02142 0.198 0.122 DBMET02143 | DBMET02143 | |
| 0.049 | 0.221 | 0.105 | Cyclooxygenase 1 inhibitor | 0.105 0.095 DBMET02141 | DBMET02141 | |
| 0.039 | 0.222 | 0.159 | Topoisomerase II inhibitor | 0.159 0.045 DBMET02142 0.117 0.07 DBMET02143 | DBMET02142 | |
| 0.025 | 0.237 | 0.094 | Topoisomerase II alpha inhibitor | 0.094 0.044 DBMET02142 0.071 0.06 DBMET02143 | DBMET02142 | |
| 0.097 | 0.314 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.061 DBMET02142 0.124 0.096 DBMET02143 | DBMET02142 | |
| 0.02 | 0.33 | 0.063 | Factor IXa inhibitor | 0.063 0.025 DBMET02142 | DBMET02142 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |